Gram-positive bacterial proteins that interact with immunoglobulins have been widely studied and utilized in immunology and biotechnology. Among the best known are Staphylococcus aureus protein A (SpA) 1 (1), streptococcal protein G (SpG) (2) , and Peptostreptococcus magnus protein L (PpL) (3). They contain from two to five successive and highly homologous Igbinding domains and recognize distinct regions on a wide portion of Ig. Protein L, a surface protein from Peptostreptococcus magnus, is 76 -106 kDa in size and contains four to five (depending on the strain) highly homologous consecutive extracellular domains (4, 5) . It binds with high affinity and high specificity to mammalian light chain variable (V L ) regions (6, 7) . Although expressed by a minority of P. magnus strains, PpL appears to be a virulence factor because its presence is correlated with enhanced vaginal colonization (8) and the concomitant occurrence of bacterial vaginosis (9) . PpL, like SpA and SpG, is an important tool for purification, recognition, and removal of immunoglobulins, but it has a different and unique specificity. SpA and SpG domains recognize a common site at the interface between the C H 2 and C H 3 domains on the Fc of IgG (Fc␥) (10, 11) , but they also interact with functionally distinct regions on the Fab portion of particular Ig families or subclasses (SpA does not bind to most IgG3, whereas SpG does) (12, 13 To understand better how PpL can bind a large population of light chains, we recently reported the crystal structure of the complex between a PpL single domain and a human Fab (14) . Surprisingly, in this structure the PpL domain is sandwiched between two antibody light chains in a manner reminiscent of cytokines binding to their receptors at the cell surface (15) (16) (17) .
From the two sites identified, only site 1 was already documented (18 -20) . To investigate the functional relevance of site 2, we have designed a PpL mutant (PpL D55A; hereafter PpL D55A ) where substitution of Asp-55 by Ala should disrupt a salt bridge and a hydrogen bond that was believed to be crucial for the interaction with PpL site 2. Thus, the PpL D55A mutant should retain only site 1 binding for V L . This mutant was built on the Y64W template, where Trp-64 is an efficient fluorescent probe to measure K d by stopped flow methods (20) .
Here, we present the complex between the PpL D55A mutant and a mouse FabЈ fragment bearing a V L 9 region to 2.1Å resolution. The structure shows how PpL is able to accommodate differences in light chain sequences. The PpL D55A mutant indeed shows a single binding mode in the crystal. To confirm the relevance of the second site in solution, we have studied the interaction between V L chains and different PpL domains by heteronuclear NMR spectroscopy. Finally, we compare the residues involved in the first and second interfaces and reveal a strong homology between the two PpL interaction patches.
EXPERIMENTAL PROCEDURES

Cloning and Nucleotide Sequencing of 19D9D6 Antibody Heavy and
Light Chains-Cloning of the 19D9D6 antibody (IgG1,) light chain was performed by standard methodology using classical PCR amplification as described previously (21) . The cDNA encoding the Fd domain of the 19D9D6 antibody was obtained using the rapid amplification of cDNA ends (RACE) method, as described previously (22) . The PCR products were obtained using the Taq DNA polymerase (Amersham Biosciences) and directly ligated into the pCR2.1 cloning vector using a TA cloning kit (Invitrogen) according to the manufacturer's instructions. The sequences of cloned DNA were determined by sequencing on an ABI 310 automatic sequencer using a Dye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems).
Antibody Fragment Generation-The antibody 19D9D6 (IgG1,) was produced in vitro and purified as follows (23) . Briefly, the supernatant was diluted 1:2 (v/v) in a high salt buffer, then loaded on a protein A column (Amersham Biosciences) and eluted at pH 6.0, following the manufacturer's instructions.
The F(abЈ) 2 fragment was obtained by proteolytic cleavage of the IgG by pepsin. The purified IgG was mixed with pepsin-agarose in an acidic buffer and digested for 1.5 h at 37°C. The pepsin-agarose was then removed by centrifugation. The F(abЈ) 2 15 N correlation spectra were recorded using the TROSY pulse sequence provided by Lewis Kay, and measuring times were 30 min for control spectra and 4 h for the PpL⅐V L complexes.
Crystallization-The FabЈ 19D9D6⅐PpL D55A complex was prepared in solution before the crystallization trials by mixing 18 l of FabЈ 19D9D6 (6 mg/ml) with 4 l of PpL D55A (16 mg/ml). Crystals were grown by vapor diffusion at room temperature in sitting drops by mixing 3 volumes of a reservoir solution containing 10% (w/w) MPEG 5000, 100 mM sodium acetate, pH 4.5, with 4 volumes of the protein solution. Crystals suitable for data collection were enlarged by using streak seeding followed by macroseeding (25) . For data collection, crystals were transferred into a cryo-solution containing 5 l of ethylene glycol, 3 l of 50% (w/w) MPEG 5000, and 10 l of 3 mM ZnCl 2 , 3 mM CdCl 2 , 100 mM sodium cacodylate, pH 6.5, and 50% (w/w) MPEG 5000. Two data sets were recorded at 100 K from isomorphous crystals to 2.6Å and later to 2.1Å resolution on ID14-EH2 and ID14-EH4 beamlines respectively (European Synchrotron Radiation Facility, Grenoble, France). Data were processed using the HKL package (26) . Crystals belong to the orthorhombic space group P2 1 2 1 2 1 . Statistics are summarized in Table I . Structure Determination and Refinement-The 25-2.6 Å data set was used to solve the structure by the molecular replacement method with the program AMORE (27) . Using the coordinates from the variable (V L /V H ) and constant (C L /C H 1) regions of the uncomplexed FabЈ 19D9D6 structure (28) as independent search models, the two FabЈ molecules present in the asymmetric unit were correctly positioned (Table I) . Any attempts to position the two PpL molecules were unsuccessful.
After an initial refinement of this model, A -weighted 2F o Ϫ F c and F o Ϫ F c electron density maps were analyzed with the program TURBO (29) . These maps show electron density corresponding to a single PpL domain in the vicinity of the V L region from both FabЈ molecules. The PpL domains were thus fitted into these maps by superimposing on both FabЈ molecules the previously solved structure of the complex between a human Fab and the PpL wt domain (14) with the program ALIGN (30) . The two FabЈ⅐PpL D55A complexes present in the asymmetric unit were first refined within the 25-2.7 Å resolution range with non-crystallographic symmetry restraints of 100 kcal/mol/Å 2 applied to the whole model with the exception of the domains involved in the interfaces and finally from 20 to 2.1 Å resolution without noncrystallographic symmetry restraints. The structure was refined with the program CNS (31), and the model was rebuilt in TURBO. Statistics for the structure determination are listed in Table I . The final model contains 994 residues, 733 water molecules, and 2 ethylene glycol molecules from the cryo-solution. Detectable residues range from 20 to 82 for the first PpL D55A domain and from 20 to 81 for the second PpL D55A domain. As observed for all PpL domain structures solved to date (14, 32, 33) , the 19 N-terminal residues are disordered and thus absent from the final model. With the exception of small loops from the C H 1 region and to a lesser extent the complementarity determining region L1, the final model is well defined in the electron density map.
Structure Analysis-All but one residue from each complex display main chain dihedral angles that fall within allowed regions of the Ramachandran plot as defined by the program PROCHECK (34) . The only exception is Ala L51 from the L2 hypervariable loop, which has been found to adopt unfavorable conformations in many crystal structures of Fab fragments. The V L conformation is unchanged between the two FabЈ molecules with a root mean square deviation (rmsd) of 0.21Å over 430 backbone atoms as calculated by the program ALIGN (30) . Similarly, both PpL D55A domains superimpose well on each other with an rmsd of 0.42Å over 240 backbone atoms with the largest shift found for the loop connecting ␤-strands 3 and 4, which is less well defined in electron density. The PpL D55A domain assumes the same three-dimensional structure as the PpL wt domain (14) , and the PpL Y64W domain solved to 1.7Å resolution (Y47W according to O'Neill numbering (33)) with rmsd of 0.5Å over 230 backbone atoms for each case.
Residues were considered to be at the interface when they fulfilled two conditions. 1) At least one van der Waals contact (cutoff ϭ 4Å; calculated with program CONTACT from the CCP4 package (35) ) is made with a residue from the partner molecule. 2) Either the residue is fully buried upon complexation, or it buries at least 20 Å 2 in the interface. The solvent-accessible surface areas were estimated with the program AREAIMOL from CCP4 (35) . Hydrogen bond distances were calculated using the program CONTACT (35) with a maximum distance cut-off of 3.4 Å and defined according to the criteria of McDonald and Thornton (36) .
RESULTS AND DISCUSSION
Overall Structure of the FabЈ 19D9D6⅐PpL D55A Complex-
The FabЈ 19D9D6 bears a V L chain belonging to the murine 9 family, which is related to the human 4 family. The asymmetric unit contains two FabЈ 19D9D6⅐PpL D55A complexes related by non-crystallographic symmetry. The two complexes superimpose on each other with a rmsd of 0.6 Å over 690 backbone atoms with the largest shift observed for the PpL helix with no consequences on the interface. In contrast with the PpL wt domain which contacts two Fab molecules in the complex with human Fab 2A2 (14) , the PpL D55A mutant binds to only one FabЈ molecule. This interaction occurs via PpL site 1 on the opposite side of the domain from the D55A mutation.
Comparison between the PpL⅐V L 9 and V L 1 Interfaces-The interactions made by PpL D55A with the V L region of FabЈ 19D9D6 (murine V L 9) are different from those observed for Fab 2A2⅐PpL wt complex (human V L 1) as a result of differences in their chain sequences. Six of the twelve V L residues involved in the Fab 2A2 V L 1⅐PpL wt complex are different in the V L 9 sequence. However, their chemical character is conserved, e.g. Ser L5 is Thr in V L 1, Ala L12 is Ser, Val L13 is Ala, Lys L18 is Arg, Ser L22 is Thr, and Lys L24 is Arg (Fig.  1A) . These changes do not affect the overall structure of the complexes which superimpose well (rmsd of 0.6 Å over 660 backbone atoms). The PpL strand ␤2 and the V L ␤-strand A are anti-parallel and are connected through hydrogen bonds between main chain atoms from both partners forming a ␤-zipper interaction. This extends a ␤-sheet from the V L region into the PpL ␤-sheet as was observed in the Fab 2A2⅐PpL wt structure (14) . Although the overall binding mode is unchanged, several interactions are different. Only 20 residues (11 from FabЈ 19D9D6 and 9 from PpL D55A ) are involved in pairwise interactions in this structure compared with 25 in the V L 1 complex (13 from the Fab 2A2 and 12 from PpL wt ). With the exception of Glu L17, which is an aspartate in Fab 2A2, all of these positions were already identified (Fig. 1, A and B) . Four hydrogen bonds out of six are common: three that mediate the formation of the ␤-zipper and one connecting PpL Tyr-53 hydroxyl to the Thr L20 carbonyl (Table II) . This confirms that these hydrogen bonds between PpL and the V L main chain are important for the recognition of a large population of V L regions in a sequence-independent manner. Surprisingly, although the serine L9 and L10 regions are conserved in FabЈ 19D9D6, the hydrogen bonds made from Ser L9 O␥ to Lys-40 N and from Ser L10 O␥ to Glu-38 O⑀1 in the Fab 2A2⅐PpL wt complex are absent in this structure because of the rotation of both serine side chains. Three additional hydrogen bonds compensate for this loss. These are created by the rearrangement of the N-terminal part of PpL strand ␤2 and of the linker region connecting the V L to the C L domain (residues L-106 to L-112). These have been found to be among the most flexible PpL and FabЈ segments. NMR studies have shown that PpL ␤2 has a faster average proton exchange rate than inner strands (␤1 and ␤4) (32, 37) . In the two crystal structures, this PpL segment adopts two alternative stable conformations (this study and Ref. 14). In the new conformation, the N-terminal portion of PpL strand ␤2 is closer to the V L strand A and makes two additional hydrogen bonds. The first one connects the Ala L12 carbonyl to the PpL Thr-36 amide, thus extending the ␤-zipper interaction by a fourth hydrogen bond (Table II and Fig. 2A ). The second links PpL Gln-35 N ⑀ 2 to the Lys L18 carbonyl. As a result, the N-terminal part of PpL strand ␤2 is more constrained than in the Fab 2A2⅐PpL wt structure ( Fig. 2A,   inset ). In addition, the movement of the main chain of Lys L107 from the V L -C L linker region combined with the rearrangement of its long side chain creates a hydrogen bond between Lys N and Thr-36 O ␥ 1. Some V L positions (L5, L143 and L24) previously identified to contact PpL play no direct role in the 19D9D6 interface. First, at position L5, the change from Thr in Fab 2A2 to Ser in the FabЈ 19D9D6 eliminates a contact with Glu-49 mediated by the Thr C␥1. Second, a difference in the V L -C L elbow angle (140°in FabЈ 19D9D6 versus 160°in Fab 2A2) eliminates the van der Waals interaction between position L143, a glutamate from the C L domain, and Lys-24 N from PpL. However, in another crystal form, as a result of a change in crystal packing, the V L -C L elbow angle of the same FabЈ complexed to another PpL mutant is 165°, and position L143 regains its role in site 1. 2 This suggests that this van der Waals interaction is of secondary importance for complex formation. At position L24, a Lys replaces an Arg. Arg L24 from site 1 in the Fab 2A2⅐PpL wt complex is involved in van der Waals interaction with PpL Arg-52 and makes a salt bridge to V L Asp L70 from another light chain bound to site 2 (Fig. 2B) . In the FabЈ 19D9D6⅐PpL D55A complex, the side chain of Lys L24 is flexible as shown by the absence of strong electron density and does not contact PpL. This is not due to the loss of site 2, because in the complex with another PpL mutant that binds to two V L regions, the Lys L24 from the FabЈ 19D9D6 bound to site 1 does not contact the other FabЈ 19D9D6 bound to PpL site 2.
2 This results in a decrease in the buried area from 1300 Å 2 for PpL wt ⅐V L 1 to 1150 Å 2 for V L 9 at site 1. In summary, although the two V L regions crystallized in complex with PpL share only 50% sequence identity among the contact residues, the PpL⅐V L interface is largely conserved. Amino acid differences, backbone movements, and side chain 2 M. G. Gore, manuscript in preparation. rearrangements modulate the overall interaction, but a conserved core of residues from both partners ensures the ability of PpL to maintain its interaction. This ensures recognition of as much as 50% of the human immunoglobulin repertoire, mainly because the ␤-zipper and Tyr-53 contact only V L backbone atoms. Thus the interaction is sequence independent, and only light chains with an altered backbone conformation escape PpL recognition (e.g. V L 2 and V L ).
Evidence for the Existence of Site 2 in Solution-In the structure presented here, the PpL region responsible for site 2 (strand ␤3 and one side of the ␣-helix) is mostly solvent exposed and is only involved in a minor crystal contact, showing that the mutagenesis has effectively targeted an important residue for site 2 (Fig. 2C) . Thus, after the truncation of the Asp-55 side chain, this mutant is unable to interact through the large contact surface found in the Fab 2A2⅐PpL wt complex but establishes instead a minor crystal contact. Other reasons could be advanced to explain the absence of site 2 interactions; first, it could be just a crystal contact, and second, it could be due to sequence differences between the V L regions of Fab 2A2 and FabЈ 19D9D6. Both possibilities are dismissed by the analysis of the crystal packing of three other PpL mutants in complex with the same FabЈ (28). The two PpL mutant domains with intact site 2 (the modified residues Tyr to Phe at position 53 or Leu to His at position 57 are both in site 1) are sandwiched between two FabЈ 19D9D6 exactly as observed for the complex between human Fab 2A2 and PpL wt (Ref. 14 and Fig. 2D ). The third construct where residues Asp-55 and Leu-57 have been mutated to Ala and His, respectively, crystallizes in a different crystal form and binds to the FabЈ only through site 1 (Fig. 2E) . This provides strong evidence to support the claim that the aspartic residue at position 55 plays a key role in site 2, and its replacement by an alanine is sufficient to disrupt this site.
To complement x-ray crystallographic data, we have used heteronuclear solution NMR spectroscopy to map the V L binding site of PpL with human V L 1 in combination with the TROSY method (38) . Spectra obtained by this approach should allow a clearer observation of resonances in the complex with a gain in sensitivity compared with previous NMR studies (18) . We have compared the chemical shifts induced on two different PpL domains, PpL wt and PpL D55N (but not PpL D55A because of aggregation problems), upon V L binding at two different PpL⅐V L 1 ratios (2:1 and 1:1). At a 2:1 ratio, both PpL wt and PpL D55N 1 H-15 N HSQC spectra show a mixture of complexed and uncomplexed species as evident from the persistence of cross peaks at the native chemical shifts and the appearance of a set of weak and broad signals (Fig. 3, A and C) . Upon continuation of the titration to a 1:1 stoichiometry, the PpL wt spectrum becomes almost completely broadened out with the exception of intense signals from the N-terminal residues (Fig.  3B) . This is consistent with the formation of a complex of larger molecular weight that does not involve the disordered N-terminal residues as seen by crystallography (14) . Conversely, the equivalent PpL D55N spectrum still displays visible backbone resonances at the 1:1 stoichiometry (Fig. 3D ). This is a clear indication that the overall binding of PpL D55N to V L 1 chains has been reduced relative to PpL wt .
For an analysis of the possible V L binding sites on PpL, the PpL wt and PpL D55N spectra at 2:1 PpL⅐V L 1 molar ratio proved to be the most useful (Fig. 3E) . We have focused on some residues from PpL site 2 (Glu-44, Asp or Asn-55, Asp-67, Leu-68, and Gly-72). Whereas these residues in PpL wt clearly show a set of weak shifted peaks associated with the main peaks (Fig. 3E, left panel) , these weak peaks are largely absent in the PpL D55N spectrum (Fig. 3E, right panel) , although a small perturbation for both Asn-55 and Leu-68 is visible, indicating that some weaker association may persist at site 2.
The above NMR results clearly demonstrate different V L 1 binding properties for PpL wt and PpL D55N domains. They also confirm the existence of site 2, which is weakened by the Asp-55 to Asn substitution (and most probably by the Asp to Ala). This raises the number of V L binding sites on the whole PpL molecule from five to ten (or from four to eight, depending on the P. magnus strain). Since its discovery, PpL was considered to bear only one V L binding site on each domain, and all the previous conclusions were based on this assumption. These new results are important and allow a more precise interpretation of the biological activity of PpL. Through these two sites, PpL is able to interact with many antibodies outside the antigen combining site in a manner reminiscent of SpG and SpA. As in the binding properties shown by SpA and SpG domains, dual site binding renders PpL inaccessible to antibodies, which may serve to effectively hide the bacterial protein and the bacterium from immune surveillance. What role this mechanism plays in the defense strategy of these bacteria remains to be established. However, like SpA, PpL can act as a B-cell superantigen through its Fab binding property, (39) .
Structural (14) . The other residues are in yellow with the exception of the matching hydrophobic residues, which are in green (PpL Tyr-51 and Tyr-53) or magenta (PpL Phe-39 and Tyr-64). The PpL domain is rotated by 180°relative to the V L region, which has the same orientation in both cases. B, matching between PpL residues involved in site 1 (green) or in site 2 (cyan). C, ␤-zipper interactions involved in site 1 (left) and site 2 (right). Hydrogen bonds responsible for each interaction are depicted by dotted lines. The fourth main chain to main chain hydrogen bond highlighted by the present structure at site 1 is in green.
ternary complex and buries a similar area (1300 Å 2 for site 1 and 1400 Å 2 for site 2) (Fig. 4A) . Superimposition of the V L region of the two Fabs in complex with PpL wt brings both PpL sites into alignment, exposing a strong similarity between the two interfaces. Asp-55 overlies Glu-49, Tyr-53 maps on Tyr-51, Ala-37 on Ala-66, Arg-52 overlies itself, and the other corresponding residues have a matching chemical character (Fig.  4B ). This includes Phe-39 that overlays Tyr-64, both of which have been mutated to Trp without affecting binding at either site (19, 28) . The structural mimicry between the two interfaces is also found at the secondary structure level. Both PpL binding sites involve a whole ␤-strand and one side of an ␣-helix, although strand A from the V L region is anti-parallel to PpL strand 2 (site 1) but parallel to PpL strand 3 (site 2) (Fig. 4C) . These strand-to-strand interactions are of the ␤-zipper type with four hydrogen bonds made between site 1 of PpL D55A and FabЈ 19D9D6 compared with only two hydrogen bonds formed between site 2 of PpL wt and Fab 2A2. The superimposition can guide a program of mutagenesis to establish which residues found in a PpL domain are essential in each of the two closely related V L light chain binding sites and whether or not the two sites share critical residues.
It is surprising to find that the two sites appear not to be the result of gene duplication but the result of functionally driven structural convergence. Although such a strong structural mimicry has not been observed before, other molecules have developed two non-identical binding sites to the same target. The extracellular ligands of class 1 cytokine receptors, like human growth hormone (hGH) and erythropoietin (EPO) bind to their receptors divalently with a one ligand-two receptor stoichiometry (15) (16) (17) . In the three cases, two different sites on the ligand contact similar regions of the receptors. However, in the case of hGH and EPO, the strong mimicry described above is not present. The PpL⅐V L interactions better resemble the interaction of EPO with its receptor because of the lack of receptorreceptor contacts and the unequal affinities between the two binding sites (three orders of magnitude difference for EPO (40) ). What are the consequences of a PpL domain binding to two B-cell receptors? Does the presence of a second binding site offer a biological advantage to a protein that already has up to five sequential Ig binding domains? In the case of EPO, it has been shown that not all dimerization will lead to activation (41) . It is thus possible that a similarity may exist between the manner in which PpL interacts with B cell receptors and the way that cytokines interact with their receptors. From a structural point of view, a flexible string of domains may not give a precise signal in the same way that single-domain PpL-dimerized receptors could. The analogy is very suggestive and merits further investigation.
In conclusion, these results enhance our knowledge of the mechanism adopted by PpL to interact with almost half of the human B cell repertoire overcoming sequence variation at the recognized V L positions. By combination of x-ray crystallography and NMR methods, we confirm the existence of two independent, simultaneous V L binding sites on a single PpL domain.
